Fonte: Clinical Chemistry. Nome do evento: American Association for Clinical Chemistry Annual Meeting/AACC. Unidades: FCF, HU
Assuntos: HIPERCOLESTEROLEMIA, POLIMORFISMO
ABNT
WILLRICH, Maria Alice Vieira et al. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 ago. 2024. , 2010APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Hirata, M. H., et al. (2010). Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2024 ago. 23 ]Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2024 ago. 23 ]